[{"data": {"name": "Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibody", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "R M Sharkey", "@type": "Person"}, {"name": "H Karacay", "@type": "Person"}, {"name": "C-H Chang", "@type": "Person"}, {"name": "W J McBride", "@type": "Person"}, {"name": "I D Horak", "@type": "Person"}, {"name": "D M Goldenberg", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.nature.com/articles/2403751.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Nature", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1038/sj.leu.2403751", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCfLkycmx51fg-CTcANM7ooDZDY-CDWcS5YFZoFa1-CRV8u3EdZHT4M", "propertyID": "ISCC"}], "datePublished": "2005-04-07"}, "schema": "schema.org", "mediatype": "application/ld+json"}]